...
首页> 外文期刊>Journal of separation science. >Simultaneous determination of 15 marker constituents in various Radix Astragaii preparations by solid-phase extraction and high-performance liquid chromatography
【24h】

Simultaneous determination of 15 marker constituents in various Radix Astragaii preparations by solid-phase extraction and high-performance liquid chromatography

机译:固相萃取和高效液相色谱法同时测定各种黄芪制剂中的15种标记物成分

获取原文
获取原文并翻译 | 示例
           

摘要

An improved quality control method was developed to simultaneously determine 15 major constituents (eight flavonoids and seven saponins) in various Radix Astragali preparations, using SPE for pretreatment of samples, HPLC with diode-array and evaporative light scattering detectors (DAD-ELSD) for quantification in one run, and HPLGESI-TOF/MS for definite identification of compounds in preparations. Optimum separations were obtained with a ZORBAX C-18 column, using a gradient elution with 0.3% aqueous formic acid and ACN. This established method was fully validated with respect to linearity, precision, repeatability, and accuracy, and was successfully applied to quantify the 15 compounds in 19 commercial samples, including 3 dosage forms, i.e., oral solution, injection, concentrated granule, and its processed products of Radix Astragali. The results demonstrated that many factors might result in significant differences in quality of the final preparations, including crude drugs, pretreatment processes, manufacturing procedure, storage conditions, etc. Then the developed method provided a reasonable and powerful manner to ensure the efficacy, safety, and batch-to-batch uniformity of Radix Astragali products by standardizing each procedure, and thus should be proposed as quality control for the clinical use and modernization of herbal preparations.
机译:开发了一种改进的质量控制方法,可同时测定各种黄芪制剂中的15种主要成分(8种黄酮类化合物和7种皂苷),使用SPE进行样品预处理,带二极管阵列的HPLC和蒸发光散射检测器(DAD-ELSD)进行定量一次运行,然后使用HPLGESI-TOF / MS来确定制剂中的化合物。使用ZORBAX C-18色谱柱,使用0.3%甲酸水溶液和ACN进行梯度洗脱,可获得最佳分离效果。该建立的方法在线性,精密度,可重复性和准确性方面得到了充分验证,并且已成功地用于量化19种商业样品中的15种化合物,包括3种剂型,即口服溶液剂,注射剂,浓缩颗粒剂及其加工方法黄芪产品。结果表明,许多因素可能会导致最终制剂质量的显着差异,包括原料药,预处理过程,制造程序,储存条件等。然后,所开发的方法为确保有效性,安全性,合理性和有效性提供了合理而有效的方法。通过标准化每个程序对黄芪产品的批次和批次之间的均匀性,因此应被建议作为草药制剂临床使用和现代化的质量控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号